Table 2 Microbiological results
Primary patients | Referred patients | p-value | ||
|---|---|---|---|---|
Culture-positive/Total patients | 10/11 | 27/34 | 0.657 | |
Mono/Polymicrobial | 10/0 | 20/7 | 0.155 | |
Identified Organisms | 10 | 35 | ||
Gram-positive cocci | MSSA | 8 | 1 | < 0.001 |
MRSA | 0 | 14 | 0.006 | |
Streptococcus species | 0 | 5 | 0.295 | |
Enterococcus faecalis | 0 | 1 | 1.0 | |
Gram-negative bacteria | Pseudomonas aeruginosa | 1 | 3 | 1.0 |
Pasteurella species | 1 | 2 | 1.0 | |
Eschericia coli | 0 | 2 | 1.0 | |
Enterobacter cloacae | 0 | 2 | 1.0 | |
Proteus vulgaris | 0 | 2 | 1.0 | |
Prevotella species | 0 | 1 | 1.0 | |
Aeromonas sobria | 0 | 1 | 1.0 | |
Fungal infection | Candida parapsilosis | 0 | 1 | 1.0 |
Susceptibility to cefazolin (yes/no) | 9/1 | 4/23 | < 0.001 | |